Aprotinin in high-risk isolated coronary artery bypass graft patients: a 3-year propensity matched study

Aprotinin in high-risk isolated coronary artery bypass graft patients: a 3-year propensity matched study

Abstract Background Aprotinin, a serine protease inhibitor, has been used variably in cardiac surgery amidst ongoing debates about its safety following several previous studies. This study assesses the outcomes of aprotinin in high-risk isolated Coronary Artery Bypass Graft (iCABG) patients. Methods...

Full description

Bibliographic Details
Main Authors: Rishab Makam, Ayush Balaji, Marwan Al Munaer, Shantanu Bajaj, Nabil Hussein, Mahmoud Loubani
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Aprotinin
Isolated coronary artery bypass graft
High-risk surgery
Anti-fibrinolytics
Bleeding
Transfusion
Online Access:https://doi.org/10.1186/s13019-024-02837-1

Internet

https://doi.org/10.1186/s13019-024-02837-1

Similar Items